SHARE YOUR STORY: Exercise
The National Institute of Health has funded numerous studies that yielded findings supportive of the claim that exercise is a useful adjunct therapy for individuals diagnosed with Parkinson’s disease.
Do YOU have a regular exercise program?
What exercises have helped you the most?
Friday, July 29, 2011
Thursday, July 28, 2011
New Research Reports Some Welders Develop Symptoms with a Parkinson’s Resemblance
Published in the medical journal Neurology, new research finds an increased incidence of mild movement disorder symptoms in career welders. Compared to non-welders, welders had an 11.7 percent reduction in a dopamine marker. Due to the small size of the study (only 60 participants total) more research is needed.
Welders are often exposed to manganese, a trace mineral that past research has linked to neurological disorders, including Parkinson's disease.
Study authors stress that the motor deficiencies observed in the welder study subjects are not demonstrative of classic Parkinson’s disease, but more of an off-shoot presumably resulting from dopamine deficiency.
http://ping.fm/1asEj
Published in the medical journal Neurology, new research finds an increased incidence of mild movement disorder symptoms in career welders. Compared to non-welders, welders had an 11.7 percent reduction in a dopamine marker. Due to the small size of the study (only 60 participants total) more research is needed.
Welders are often exposed to manganese, a trace mineral that past research has linked to neurological disorders, including Parkinson's disease.
Study authors stress that the motor deficiencies observed in the welder study subjects are not demonstrative of classic Parkinson’s disease, but more of an off-shoot presumably resulting from dopamine deficiency.
http://ping.fm/1asEj
Wednesday, July 27, 2011
One More Cup of Coffee
Coffee staves off PD? A new AMA study says yes, but can’t say specifically why.
A recent study published in the Journal of the American Medical Association found 3-5 times less incidences of PD in coffee drinkers (who drank approx. five cups a day) than in non-coffee drinkers.
While this prognosis was originally attributed to coffee’s caffeine content, studies were unable to replicate these results by administering other sources of caffeine.
The jury is still out as to why coffee may stave off Parkinson's.
http://ping.fm/LKyvd
Title: Bob Dylan
Image: www.fanpop.com
Coffee staves off PD? A new AMA study says yes, but can’t say specifically why.
A recent study published in the Journal of the American Medical Association found 3-5 times less incidences of PD in coffee drinkers (who drank approx. five cups a day) than in non-coffee drinkers.
While this prognosis was originally attributed to coffee’s caffeine content, studies were unable to replicate these results by administering other sources of caffeine.
The jury is still out as to why coffee may stave off Parkinson's.
http://ping.fm/LKyvd
Title: Bob Dylan
Image: www.fanpop.com
Tuesday, July 26, 2011
New Rodent Model Study May Offer Clues to Alternative Treatments for PD
Few treatments for Parkinson's disease (PD) restore function for extended periods of time. A new study published in the inaugural issue of Journal of Parkinson's Disease, found that platelet-derived growth factor-BB (PDGF-BB) therapy restored long-term functional improvements in experimental models of Parkinson's disease in rodents.
An international group of researchers reported that an infusion of PDGF-BB counteracted classic PD behavioral, tissue and biochemical changes.
Study authors concluded that PDGF-BB shows promise as a clinical candidate drug for the treatment of PD in humans.
http://ping.fm/ke10M
Few treatments for Parkinson's disease (PD) restore function for extended periods of time. A new study published in the inaugural issue of Journal of Parkinson's Disease, found that platelet-derived growth factor-BB (PDGF-BB) therapy restored long-term functional improvements in experimental models of Parkinson's disease in rodents.
An international group of researchers reported that an infusion of PDGF-BB counteracted classic PD behavioral, tissue and biochemical changes.
Study authors concluded that PDGF-BB shows promise as a clinical candidate drug for the treatment of PD in humans.
http://ping.fm/ke10M
Monday, July 25, 2011
Lithium Protects the PD-Brain?
A recent study from the Buck Institute for Research on Aging in California found that the drug lithium greatly prevented the buildup of toxic proteins and brain cell loss linked to Parkinson's disease. The results, found using laboratory mice, were published in last month’s issue of the Journal of Neuroscience Research.
Previous animal studies have also demonstrated lithium’s neuroprotective effect in regards to Huntington's disease, and Alzheimer's disease. Investigators at the Buck Institute for Research on Aging have started preclinical studies to determine the proper lithium dosage for humans, and hope to soon initiate Phase II clinical trials in conjunction with Parkinson's disease.
http://ping.fm/85KJN
A recent study from the Buck Institute for Research on Aging in California found that the drug lithium greatly prevented the buildup of toxic proteins and brain cell loss linked to Parkinson's disease. The results, found using laboratory mice, were published in last month’s issue of the Journal of Neuroscience Research.
Previous animal studies have also demonstrated lithium’s neuroprotective effect in regards to Huntington's disease, and Alzheimer's disease. Investigators at the Buck Institute for Research on Aging have started preclinical studies to determine the proper lithium dosage for humans, and hope to soon initiate Phase II clinical trials in conjunction with Parkinson's disease.
http://ping.fm/85KJN
Friday, July 22, 2011
Can Motorized Stationary Cycling Provide the Same Tested Benefits as Cleveland Clinic’s Forced Tandem Cycling Trials?
Dr. Jay Alberts of the Cleveland Clinic, made famous by his research linking the tandem cycling’s positive effects on those with Parkinson’s, is at it again – this time, testing motorized stationary bicycles.
Alberts original clinical trials discovered that stationary tandem riding with the patient in the back and a trainer in the front forces Parkinson patients to ride faster than they normally would, which challenges the body and the brain. Alberts says this releases dopamine and activates the part of the brain that controls body movement, which may explain the improvement in symptoms.
His new research, which he began in June 2011, will seek to discern whether motorized stationary cycling can produce the same reduction in PD symptoms as his original study.
http://ping.fm/K2ly3
Dr. Jay Alberts of the Cleveland Clinic, made famous by his research linking the tandem cycling’s positive effects on those with Parkinson’s, is at it again – this time, testing motorized stationary bicycles.
Alberts original clinical trials discovered that stationary tandem riding with the patient in the back and a trainer in the front forces Parkinson patients to ride faster than they normally would, which challenges the body and the brain. Alberts says this releases dopamine and activates the part of the brain that controls body movement, which may explain the improvement in symptoms.
His new research, which he began in June 2011, will seek to discern whether motorized stationary cycling can produce the same reduction in PD symptoms as his original study.
http://ping.fm/K2ly3
Thursday, July 21, 2011
New Research Suggests Stem Cells Delivered Intranasally Improve Motor Function in Parkinson’s Disease
Using a rat model of Parkinson’s disease, new research published in the journal Rejuvenation Research demonstrated that stem cells delivered intranasally survived for at least six months in the brain, that the stem cells rapidly migrated preferentially to the damaged areas of the brain, and that motor control showed significant improvement.
Researchers theorized this likely occurred because of the demonstrated anti-inflammatory and neuroprotective effects of the stem cells, which were derived from bone marrow.
Study authors concluded that intranasal administration of stem cells to the human brain is a promising and noninvasive alternative to current surgical procedures. It also opens up the possibility of chronic stem cells treatment, which would increase the number of cells delivered to the brain and likely enhance the therapeutic benefit.
This research was funded by the Alzheimer’s Research Center, a nationally recognized research hub conducting studies on Alzheimer’s, Parkinson’s disease, and other neurodegenerative disorders.
http://ping.fm/oE5XK
Using a rat model of Parkinson’s disease, new research published in the journal Rejuvenation Research demonstrated that stem cells delivered intranasally survived for at least six months in the brain, that the stem cells rapidly migrated preferentially to the damaged areas of the brain, and that motor control showed significant improvement.
Researchers theorized this likely occurred because of the demonstrated anti-inflammatory and neuroprotective effects of the stem cells, which were derived from bone marrow.
Study authors concluded that intranasal administration of stem cells to the human brain is a promising and noninvasive alternative to current surgical procedures. It also opens up the possibility of chronic stem cells treatment, which would increase the number of cells delivered to the brain and likely enhance the therapeutic benefit.
This research was funded by the Alzheimer’s Research Center, a nationally recognized research hub conducting studies on Alzheimer’s, Parkinson’s disease, and other neurodegenerative disorders.
http://ping.fm/oE5XK
Subscribe to:
Posts (Atom)